UNVC: The Fantasy Propaganda Dalton spread over the past 4

New Post Public Reply Private Reply Replies (1) Message Board
toodles toodles #5769
691
UNVC: The Fantasy Propaganda Dalton spread over the past 4 plus years, this isn't all but you will get the idea. None of the statements he told other investors to post are in these, here is a couple!!!! March 2020 Medicare approval then we up list, Up listing to Nasdaq 1st quarter of 2021.

These are all directly from the 2 Social Media Accounts(Twitter-LinkedIn) of CEO David Dalton.

You can draw your own decision.

A Wise man once told me if you believe all the BS from a person promising you wealth only in words (With No Actions to back up their claims) then you are the bigger fool,(I agree) when they tell you with such as this, biggest Red Flags ever, I want fail never, not in my DNA or type A personality you better listen, but not with greed

Where is any actions other than WORDS, No actions No PR's Not in any filings.(1 Thing the float doubled)

We don't need to hear his excuses, because his actions has already Spoke the truth.

2019
06/21/2019- Longs I have a rainbow of Dollars for you.
06/28/2019 - PR will make new beginnings.
07/23/2019- The Gold Standard!!!! Post Market/Premarket Book It.
08/01/2019- Love it when Auditors and Attorneys agree.
08/21/2019-I promised a Rainbow.
08/29/2019-Can't spell Conglomerate spell Lawsuit.
09/04/2019- Ask pennies get pennies Ask Dollars get Dollars.

2020
01/20/2020- Euromed standby.
02/02/2020-WellnessRx The GOLD standard, support for Pharmacist
03/06/2020-Step by Step
04/14/2020-We are almost there.
08/27/2020-Univec's app MiMi RX with Eagle Force. My Vax also
09/28/2020-Univec's Transdermal Vitamin D Patch
10/19/2020-Pennies to Dollars -Nasdaq
12/31/2020-I made a promise time for me to deliver.

2021
01/03/2021 Google Amazon/Apple Health All leads to Univec.
02/05/2021-Bringning it all together.
03/01/2021-Almost there!!
04/28/2021-Train is Leaving the Station.
08/06/2021 Final Steps.
08/22/2021-Last steps of the system process.
10/01/2021-Next week a big week.
12/24/2021-Change coming
12/22/2021-Documents being prepared for signature, delivery a happy NY

2022
02/10/2022-Greatness Admiral Legend.
03/25/2022-Next week good news and announcement.
06/10/2022-UNIVECMETAVERSE.
09/01/2022-Creating Wealth.
12/25/2022- Happy Holidays from a quiet place on the ocean.

2023
01/092023- Bureaucracy, Regulations, old procedures, want stop success.
01/16/2023-You have to walk it not TALK it.
02/23/2023-Last piece needed, Completed Train has arrived!!!!
03/05/2023-Everyone's Lane.
03/15/2023-Time for change Color Green as in Money!!!!
04/14/2023-Get Ready.
04/15/2023-Step by Step.
05/30/2023-Added 1.4 billion shares to the float.
06/01/2023-Another successful Step.
06/07/2023-Step by Step.

No one can pump a stock like Dalton, only thing is every quarter/year Univec Inc. gets more and more in debt. Less and less business.

Daltons in a conner bad he has to produce something. If not, they will be a big deprecation in the PPS. It's coming.



Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 33

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 37

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 29

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 40

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 44

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights from APA Corporation's Q3 2024 Financial Update

Updated Category News Views 291

Insights from APA Corporation's Q3 2024 Financial Update HOUSTON -- APA Corporation (Nasdaq: APA) has released key information regarding its third-quarter 2024 financial and operational results. This supplemental information serves as a guide for investors, analysts, and stakeholders to help them form their own estimates regarding the company's performance. Understanding...

Continue Reading
Exploring the Growing Trends in the US Coffee Market to 2034

Updated Category News Views 394

Insights on the US Coffee Market Growth The US coffee market is currently gearing up for an exciting decade ahead, with projections indicating it could reach USD 150.88 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.8% from 2025. This surge is largely influenced by shifting consumer preferences towards premium and specialty coffee, along with an...

Continue Reading
Insights into Great Lakes Dredge & Dock's Upcoming Earnings

Updated Category News Views 125

Understanding the Upcoming Earnings Announcement Great Lakes Dredge & Dock (NASDAQ: GLDD) is gearing up for its quarterly earnings report, and investors are eager to glean insights from the announcement. The anticipation is palpable as analysts forecast an earnings per share (EPS) of $0.09, signalling potential growth for the company. Market Reactions and Guidance It's...

Continue Reading
Calmére Estate Winery Sold, Signaling Growth in Napa Valley

Updated Category News Views 306

Calmére Estate Winery Changes Hands in Major Sale Napa Valley has long been a beacon for wine enthusiasts and savvy investors alike. The recent transaction involving Calmére Estate Winery showcases the continued potential of this iconic region. The winery, known for its exquisite Chardonnay and Pinot Noir, has been a part of the Carneros American Viticultural Area (AVA)...

Continue Reading
Mr. Splash Car Wash Partners with NBA Stars for Growth

Updated Category News Views 204

Mr. Splash Car Wash Takes a Strategic Step Forward Mr. Splash Car Wash, a notable name in the express car wash industry, has recently entered into a strategic partnership with NBA stars Giannis and Thanasis Antetokounmpo, along with Michael Carter-Williams. This collaboration aims to elevate the brand's presence in the Midwest, showcasing Mr. Splash's commitment to...

Continue Reading